The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy
Vox Sang
.
2020 Nov;115(8):603-605.
doi: 10.1111/vox.12928.
Epub 2020 Apr 13.
Authors
Massimo Franchini
1
2
,
Albert Farrugia
1
3
,
Claudio Velati
1
,
Alessandro Zanetti
4
,
Luisa Romanò
4
,
Giuliano Grazzini
1
,
Nadia Lopez
1
,
Ilaria Pati
1
,
Giuseppe Marano
1
,
Simonetta Pupella
1
,
Giancarlo Maria Liumbruno
1
Affiliations
1
Italian National Blood Centre, National Institute of Health, Rome, Italy.
2
Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
3
Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia.
4
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
PMID:
32240543
PMCID:
PMC7228285
DOI:
10.1111/vox.12928
No abstract available
Publication types
Comment
MeSH terms
Blood Safety
Blood Transfusion
COVID-19*
Coronavirus*
Disease Outbreaks
Humans
Italy / epidemiology
SARS-CoV-2